| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Seca6g00063 | ATGGCCGAGAACGATTCAAATCCCACTCCTCCACCACAGCCCCAGGAGCACGACGCTGATTTATCCACTGTAACTGTGGAACCGGAGAAGAAACCACTGTCTCCAGAGTCACAGAATGATGCAAAACCTAACCCTAACTCTTCAGAGGATGATGCAAAACCTAACCCTAACCCTTCAGAGGATGTGGTTGTGGTTGAACAACGTGAAGCGGAGGAAGAAGAGCTTCTGCAGCAGCACAAGATTCCTCAGAATTTGGTGTCCTTCAAGGAGGAGAGCAATAGGGTTTGCGATCTCTCAGATTCAGAGAGAAAGGCCGTTGAAGACCTCAAACACCTTCTAACTGAGTCACTCACTTCTTCTTCTTCCGAGGAGGAGGAGGGAGTTTCCATTTGGGGCGTTCCTCTGCTCAAAGACGAAAGGACCGATGTCATTCTTCTCAAATTCCTCAGAGCCAGAGAGTTCAAAGTGAAGGACGCGCTTCTCATGATCAACAACACGCTCCAATGGAGGAAGGACTTCAACATCGACGCGCTTTTGGATGAAGATCTCGGTGATGATTTGGACAAGGTCGTCTTCATGCACGGTCATTCAAGAGAGGGCCACCCTGTCTGTTACAATGTCTATGGTGAGTTTCAGAACAAGGACCTTTATCACAAGGCTTTCTCAGATGAGGAAAGAAGAACCAAGTTCCTACGATGGCGGATTCAGTTCTTGGAAAAGAGTATTAGGAACCTTGACTTCACTCCTGGGGGTATCAACACCATTTTCCAAGTCAATGACCTTAAAAATTCCCCTGGACCTGCTAAAAGGGAACTTCGACTTGCCACCAAACAAGCTTTGCAATTGCTTCAGGACAATTATCCTGAGTTTGTTGCCAAACAGGTTTTTATCAATGTCCCCTGGTGGTATCTTGCATTCTATACCATGATCAATCCTTTCTTGACTCAGAGGACAAAAAGCAAATTTGTGTTTGCAGGCCCATCCAAGTCTCCTGATACACTTTTCAAGTTAGTCAAGTGA | 1020 | 0.4618 | MAENDSNPTPPPQPQEHDADLSTVTVEPEKKPLSPESQNDAKPNPNSSEDDAKPNPNPSEDVVVVEQREAEEEELLQQHKIPQNLVSFKEESNRVCDLSDSERKAVEDLKHLLTESLTSSSSEEEEGVSIWGVPLLKDERTDVILLKFLRAREFKVKDALLMINNTLQWRKDFNIDALLDEDLGDDLDKVVFMHGHSREGHPVCYNVYGEFQNKDLYHKAFSDEERRTKFLRWRIQFLEKSIRNLDFTPGGINTIFQVNDLKNSPGPAKRELRLATKQALQLLQDNYPEFVAKQVFINVPWWYLAFYTMINPFLTQRTKSKFVFAGPSKSPDTLFKLVK. | 340 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Seca6g00063 | 339 | CDD | SEC14 | 189 | 338 | IPR001251 | - | |
| Seca6g00063 | 339 | MobiDBLite | consensus disorder prediction | 37 | 53 | - | - | |
| Seca6g00063 | 339 | Pfam | CRAL/TRIO, N-terminal domain | 113 | 165 | IPR011074 | - | |
| Seca6g00063 | 339 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 180 | 339 | IPR001251 | - | |
| Seca6g00063 | 339 | PANTHER | PATELLIN-1 | 54 | 338 | IPR044834 | GO:0008289 | |
| Seca6g00063 | 339 | MobiDBLite | consensus disorder prediction | 1 | 71 | - | - | |
| Seca6g00063 | 339 | PRINTS | Cellular retinaldehyde-binding protein signature | 307 | 326 | - | - | |
| Seca6g00063 | 339 | PRINTS | Cellular retinaldehyde-binding protein signature | 144 | 166 | - | - | |
| Seca6g00063 | 339 | SMART | CRAL_TRIO_N_2 | 141 | 166 | IPR011074 | - | |
| Seca6g00063 | 339 | SMART | sec14_4 | 185 | 339 | IPR001251 | - | |
| Seca6g00063 | 339 | Gene3D | - | 91 | 339 | IPR036865 | - | |
| Seca6g00063 | 339 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 92 | 182 | IPR036273 | - | |
| Seca6g00063 | 339 | Pfam | CRAL/TRIO domain | 190 | 338 | IPR001251 | - | |
| Seca6g00063 | 339 | SUPERFAMILY | CRAL/TRIO domain | 190 | 338 | IPR036865 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Seca6g00063 | Seca-Chr6 | 1552852 | 1555567 | Dispersed/Tandem |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Seca6g00063 | 145 | 338 | Acyl Lipid Metabolism Gene Families | AT5G47730 | 26.829 | 3.86e-11 | 61.6 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Seca6g00063 | - | - | mnt:21391677 | 423.705 |